AIP
CL icon

Almanack Investment Partners’s Colgate-Palmolive CL Stock Holding History

Almanack Investment Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Buy
+2,669
New +$234K 0.03% 265
2022
Q4 		– Sell
-159
Closed -$11K – 360
2022
Q3 		$11K Buy
+159
New +$12.5K ﹤0.01% 459

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Almanack Investment Partners's CL Position: Q2 2026 in Review

Almanack Investment Partners opened a new position in Colgate-Palmolive (CL) in Q2 2026: 2,669 shares worth $245K. The stake represents 0.03% of the portfolio and ranks #265 among its holdings. This is a return to the name: Almanack Investment Partners previously reported a position in CL as recently as Q3 2022.

Almanack Investment Partners first reported a position in CL in Q3 2022 and has held it in 2 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Almanack Investment Partners held 2,669 shares of Colgate-Palmolive worth $245K as of Q2 2026.
  • Colgate-Palmolive was a new Almanack Investment Partners position in Q2 2026.
  • Colgate-Palmolive made up 0.03% of Almanack Investment Partners's portfolio in Q2 2026, its #265 holding.
  • Almanack Investment Partners first reported a position in Colgate-Palmolive in Q3 2022 and has held it in 2 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Almanack Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.